In 2015, based on the evidence available at the time, WHO released a policy guideline on the use of LAM stating that the test may be used to assist in the diagnosis of TB in HIV-positive adults with signs and symptoms of TB who are seriously ill or have a CD4 count less than or equal to 100 cells/μl [17]. The gene discussed is CD4; the disease is tuberculosis.